Search

Your search keyword '"Felten, Renaud"' showing total 367 results

Search Constraints

Start Over You searched for: Author "Felten, Renaud" Remove constraint Author: "Felten, Renaud"
367 results on '"Felten, Renaud"'

Search Results

1. Recommandations de la Société française de rhumatologie pour la prise en charge en pratique courante des patients atteints de pseudopolyarthrite rhizomélique

2. Unmet needs in axial spondyloarthritis. Proceedings of the French spondyloarthritis taskforce workshop

5. Recommendations of the French Society of Rheumatology for the management in current practice of patients with polymyalgia rheumatica

7. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

8. Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study

12. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

18. COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infection

21. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

23. Recommandations de la Société Française de Rhumatologie pour la prise en charge en pratique courante des patients atteints de Pseudo Polyarthrite Rhizomélique

24. Points to consider for unmet needs in axial spondyloarthritis. Proceedings of the French spondyloArthritiS Taskforce workshop

26. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

27. Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

28. Refining “Long-COVID” by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection

29. Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

30. Examining the biological pathways underlying clinical heterogeneity in Sjogren's syndrome : proteomic and network analysis

31. Prevalence and characteristics of, and knowledge related to, photosensitivity in patients with lupus erythematosus: the international PHOTOLUP study.

33. Repurposing the Fibrosis-4 Score in Rheumatoid Arthritis: Data from the ESPOIR Cohort

34. LC3-associated phagocytosis is impaired in monocyte-derived macrophages from systemic sclerosis patients

35. Concordance and agreement between different activity scores in polymyalgia rheumatica

38. Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France

41. IL-17 inhibitors in axial spondyloarthritis. An overview

42. Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study

44. Examining the biological pathways underlying clinical heterogeneity in Sjogren’s syndrome: proteomic and network analysis

47. Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study

48. Identification of new candidate drugs for primary Sjögren's syndrome using a drug repurposing transcriptomic approach.

Catalog

Books, media, physical & digital resources